Übersichtsarbeiten - OUP 01/2020

Wie effektiv ist die Injektionsbehandlung im Bereich des Hüftgelenks?

15. Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S: Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip? J Rheumatol 2004; 31: 2265–8

16. Lawrence RC, Helmick CG, Arnett FC et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 778–99

17. Ling SM, Bathon JM: Osteoarthritis in older adults. J Am Geriatr Soc 1998; 46: 216–225

18. Lo GH, LaValley M, McAlindon T, Felson DT: Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003; 290: 3115–21

19. Martel-Pelletier, J, Roubille, C, Abram et al.: First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis 2015; 74: 547–56

20. Micu MC, Bogdan GD, Fodor D. Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance. Rheumatology (Oxford) 2010; 49: 1490–4

21. Migliore A, Martin LS, Alimonti A, Valente C, Tormenta S: Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003; 11: 305–6

22. Moreland LW: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003; 5: 54–67

23. Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H: Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006; 14: 163–70

24. Raman R, Henrotin Y, Chevalier X et al.: Decision algorithms for the retreatment with viscosupplementation in patients suffering from knee osteoarthritis: recommendations from the EUROpean viscosupplementation consensus group (EUROVISCO). Cartilage 2017. DOI: 10.1177/1947603517693043

25. Rotbauer F, Zerwes U, Bleß HH, et al.: Häufigkeit endoprothetischer Hüft- und Knieoperationen. In: Weißbuch Gelenkersatz. Versorgungssituation bei endoprothetischen Hüft- und Knieoperationen in Deutschland. Berlin, Heidelberg: Springer Verlag 2017

26. Solignac M: COART France 2003 report on new socioeconomic data on osteoarthritis in France. [Article in French] Presse Med 2004; 33: S4–6

27. Sperati A, Picconi O, Tancioni V, Guasticchi G, Agabiti N. Outcomes of hip replacement: a hospital-based longitudinal study in Lazio region. [Article in Italian] Ann Ig 2008; 20: 141–57

28. Steinmeyer J, Bock F, Stöve J, Jerosch J, Flechtenmacher J: Pharmacological treatment of knee osteoarthritis: Special consideration of the new german guideline. Orthopedic Revies 2018, 10: 7782

29. Thomas E, Wilkie R, Peat G, Hill S, Dziedzic K, Croft P: The North Staffordshire Osteoarthritis Project—NorStOP: prospective, 3-year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 2004; 5: 2

30. Wu B, Li YM, Liu YC: Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials. Oncotarget. 2017 Sep 18; 8: 86865–76

31. Zhang W, Doherty M, Arden N et al.: EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669–681

32. Zhang W, Doherty M, Arden N et al.: Leitlinie der DGOOC: Koxarthrose_Update (S2k) Entwurf 0.3 vom 10.07.2018; Seite 44 von 83

33. Zhang W, Moskowitz RW, Nuki G et al.: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137–62

Korrespondenzadresse

Prof. Dr. med. Dr. h. c. Jörg Jerosch

Klinik für Orthopädie, Unfallchirurgie und Sportmedizin

Johanna-Etienne-Krankenhaus

Am Hasenberg 46

41426 Neuss

j.jerosch@ak-neuss.de

SEITE: 1 | 2 | 3